BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Springworks’ Gomekli wins priority FDA nod for NF1 neurofibromas
Snagging its second U.S. FDA approval since being spun out of Pfizer Inc. in 2017, Springworks Therapeutics Inc. is aiming to position Gomekli (mirdametinib), cleared for...

More in BioWorld

BioWorld MedTech

Edwards: TAVR wavers, mitral valve shines
Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company...

More in BioWorld MedTech

BioWorld Science

Plasmodium essential gene map gives malaria pharmacologic clues
Two simultaneous but independent studies published in Science identified, by introducing mutants into its genome, the essential and nonessential genes of Plasmodium knowlesi...

More in BioWorld Science

BioWorld Asia

Mixed reactions from Asia on biotech implications of Trump 2.0
“This current administration is like nothing that we've seen before,” said a managing partner of a global venture capital firm who spoke to BioWorld on the condition of...

More in BioWorld Asia

BioWorld Insider Podcast

The BioWorld Insider podcast is a monthly dive into the business and science of drug development. Conversations with CEOs and BioWorld analysts in the past 12 months have included a wide range of chats with experts who are shaping the future.